Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(1.17)
# 1919
Out of 5,358 analysts
38
Total ratings
58.82%
Success rate
8.57%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BNTX BioNTech | Maintains: Strong Buy | 95 150 | 108.54 | 38.2% | 9 | Sep 19, 2024 | |
MRNA Moderna | Upgrades: Hold | 85 80 | 27.47 | 191.23% | 8 | Aug 6, 2024 | |
GRFS Grifols | Downgrades: Sell | n/a | n/a | n/a | 2 | Mar 12, 2024 | |
AZN AstraZeneca | Downgrades: Hold | n/a | n/a | n/a | 3 | Feb 8, 2024 | |
ALVO Alvotech | Maintains: Hold | 8 12 | 10.66 | 12.57% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | n/a | n/a | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 4 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 35 | 4.4 | 695.45% | 1 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | n/a | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 1 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | n/a | n/a | n/a | 2 | Feb 4, 2021 |